1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 07 MARCH 2016

Cancer Drug News 07 MARCH 2016

  • March 2016
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Unlocking High-Potential Reservoirs Will Drive Exponential Cancer Revenue Growth
Industry Brief - FDA Approves New Indication For Faslodex
Industry Brief - Poziotinib Phase II Trial Initiated In Advanced BC
Industry Brief - Onconova Receives Rigosertib Deal Termination Notice From Baxalta
Industry Brief - Amgen Submits Blincyto sBLA To FDA
Industry Brief - EMA Grants ODD To Venetoclax In AML; Recommends Giotrif In Advance SCC
Industry Trend Analysis - AstraZeneca Faces Challenges In Navigating Transitional Period
Industry Brief - Eusa/Aveo Seek EU Marketing Approval For Tivozanib In Advanced RCC
Industry Brief - Combination Trial Of Avelumab/VS-6063 Initiated In Ovarian Cancer
Industry Brief - Debiopharm Sees Victory In Japanese Oxaliplatin Lawsuit
Industry Brief - Ono Gains Japanese Approval For Partial Change In Opdivo Labelling
Industry Brief - Yondelis Approved for Sale In Six Additional Countries
Industry Brief - Merck Enters Oncology Research Collaboration With EMBL
Industry Brief - Exelixis/Ipsen Enter Cabozantinib Licensing Deal
Industry Brief - Eisai's Halaven Approved In Japan To Treat STS
Industry Trend Analysis - Precision Medicine Development Driven By Big Data
Industry Trend Analysis - Baxalta Building Immuno-Oncology Capabilities
Industry Brief - Specialized Therapeutics/Mundipharma Enter Sublicensing Deal For Anti-Emetic Products

Table Of Contents

Cancer Drug News 07 MARCH 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.